Analysis of the public TCGA and CBCGA datasets revealed that TET3 expression levels were higher in TNBC relative to luminal‐ and HER2+ types of breast cancer (Figure S5A,B, Supporting Information). This evidence concerns the gene ERBB2 and breast carcinoma.